Karpe, Fredrik

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome

Barber, T. M., Golding, S. J., Alvey, C., Wass, J. A. H., Karpe, F., Franks, S., & McCarthy, M. I. (2008) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 179

Impaired Postprandial Adipose Tissue Blood Flow Response Is Related to Aspects of Insulin Sensitivity

Karpe, F., Fielding, B. A., Ilic, V., Macdonald, I. A., Summers, L. K. M., & Frayn, K. N. (2002) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 177

Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides

Karpe, F., Boquist, S., Tang, R., Bond, G. M., de Faire, U., & Hamsten, A. (2001) · Journal of Lipid Research

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 174

Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins

Tornvall, P., Olivecrona, G., Karpe, F., Hamsten, A., & Olivecrona, T. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 172

Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition

Small, K. S., Todorčević, M., Civelek, M., El-Sayed Moustafa, J. S., Wang, X., Simon, M. M., Fernandez-Tajes, J., Mahajan, A., Horikoshi, M., Hugill, A., et al. (2018) · Nature Genetics

Adipokines, Inflammation, and Metabolic DiseasesGenetic Associations and Epidemiology

Cited by 168

Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man

Christodoulides, C., Dyson, P., Sprecher, D., Tsintzas, K., & Karpe, F. (2009) · The Journal of Clinical Endocrinology & Metabolism

Fibroblast Growth Factor ResearchPeroxisome Proliferator-Activated Receptors

Cited by 153

Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100

Karpe, F., Bell, M., Björkegren, J., & Hamsten, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersCholesterol and Lipid Metabolism

Cited by 143

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation

Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 140

Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher Propensity for NAFLD in men

Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2015) · The Journal of Clinical Endocrinology & Metabolism

Liver Disease Diagnosis and TreatmentLipid metabolism and biosynthesis

Cited by 138

Lipoprotein lipase in plasma after an oral fat load: Relation to free fatty acids

Karpe, F., Olivecrona, T., Walldius, G., & Hamsten, A. (1992) · Journal of Lipid Research

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 118

Triglycerides and atherogenic dyslipidaemia: Extending treatment beyond statins in the high-risk cardiovascular patient

Watts, G. F., & Karpe, F. (2011) · Heart

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 97

Determinants of VLDL-triglycerides production

Nielsen, S., & Karpe, F. (2012) · Current Opinion in Lipidology

Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 94

Effects of insulin on adipose tissue blood flow in man

Karpe, F., Fielding, B. A., Ardilouze, J., Ilic, V., Macdonald, I. A., & Frayn, K. N. (2002) · The Journal of Physiology

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 81

Exercise Prevents the Accumulation of Triglyceride-Rich Lipoproteins and Their Remnants Seen When Changing to a High-Carbohydrate Diet

Koutsari, C., Karpe, F., Humphreys, S. M., Frayn, K. N., & Hardman, A. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 79

The presence of methylation quantitative trait loci indicates a direct genetic influence on the level of DNA methylation in adipose tissue

Drong, A. W., Nicholson, G., Hedman, Å. K., Meduri, E., Grundberg, E., Small, K. S., Shin, S.-Y., Bell, J. T., Karpe, F., Soranzo, N., et al. (2013) · PLoS ONE

Epigenetics and DNA MethylationGenetic Associations and Epidemiology

Cited by 79

The proposed systemic thermogenic metabolites succinate and 12,13-diHOME are inversely associated with adiposity and related metabolic traits: evidence from a large human cross-sectional study

Vasan, S. K., Noordam, R., Gowri, M. S., Neville, M. J., Karpe, F., & Christodoulides, C. (2019) · Diabetologia

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 76

Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men

Marinou, K., Adiels, M., Hodson, L., Frayn, K. N., Karpe, F., & Fielding, B. A. (2011) · British Journal Of Nutrition

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 75

Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased

Frayn, K. N., Langin, D., & Karpe, F. (2008) · Diabetologia

Adipose Tissue and MetabolismLipid metabolism and biosynthesis

Cited by 54

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Karpe, F. (2001) · Atherosclerosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 50

Bone morphogenetic protein 2 is a depot-specific regulator of human adipogenesis

Denton, N. F., Eghleilib, M., Al-Sharifi, S., Todorčević, M., Neville, M. J., Loh, N., Drakesmith, A., Karpe, F., & Pinnick, K. E. (2019) · International Journal of Obesity

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 41

Transcriptional control of human adipose tissue blood flow

Perez‐Matute, P., Neville, M. J., Tan, G. D., Frayn, K. N., & Karpe, F. (2009) · Obesity

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 32

Associations of Outdoor Temperature, Bright Sunlight, and Cardiometabolic Traits in Two European Population-Based Cohorts

Noordam, R., Ramkisoensing, A., Loh, N. Y., Neville, M. J., Rosendaal, F. R., Willems van Dijk, K., van Heemst, D., Karpe, F., Christodoulides, C., & Kooijman, S. (2019) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsCircadian rhythm and melatonin

Cited by 20

Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses

Ibi, D., Boot, M., Dollé, M. E. T., Jukema, J. W., Rosendaal, F. R., Christodoulides, C., Neville, M. J., Koivula, R., Rensen, P. C. N., Karpe, F., et al. (2022) · Journal of Lipid Research

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 9